image: Researchers model cases of tuberculosis in India over the next two decades.
Credit: nonmisvegliate, Pixabay (CC0, https://creativecommons.org/publicdomain/zero/1.0/)
India could see more than 62.4 million cases of tuberculosis in the two decades to 2040, with scaling-up of existing treatment regimens potentially generating at least US$28 billion in GDP gains
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004491
Article Title: Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully-integrated modelling study
Author Countries: United Kingdom, Denmark
Funding: This work was funded by Johnson and Johnson, New Brunswick, NJ, USA, agreement number 2110-5191. All authors received this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Journal
PLOS Medicine
Method of Research
Computational simulation/modeling
Subject of Research
Not applicable
COI Statement
Competing interests: The authors have declared that no competing interests exist.